25 January 2017 - Deborah Wilkes
Archived
Johnson & Johnson is evaluating strategic options for its Diabetes Care businesses, including blood-glucose monitoring specialist LifeScan.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.